Regeneron

Results: 62



#Item
51iCo Therapeutics July 1, 2014 Andrew Rae, President & CEO[removed]www.icotherapeutics.com / TSX-V: ICO

iCo Therapeutics July 1, 2014 Andrew Rae, President & CEO[removed]www.icotherapeutics.com / TSX-V: ICO

Add to Reading List

Source URL: www.icotherapeutics.com

Language: English - Date: 2014-07-23 09:04:29
52COMMUNIQUÉ DE PRESSE  Sanofi et Regeneron annoncent les résultats positifs d’une étude de Phase 2b du dupilumab dans le traitement de la dermatite atopique modérée à sévère – Publication aujourd’hui des ré

COMMUNIQUÉ DE PRESSE Sanofi et Regeneron annoncent les résultats positifs d’une étude de Phase 2b du dupilumab dans le traitement de la dermatite atopique modérée à sévère – Publication aujourd’hui des ré

Add to Reading List

Source URL: www.sanofi.com

Language: French - Date: 2014-07-09 16:57:14
    53PRESS RELEASE  Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis - Results from Earlier Clinical Trials Published Today in the New Engla

    PRESS RELEASE Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis - Results from Earlier Clinical Trials Published Today in the New Engla

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-07-09 16:57:27
    54Regeneron Pharmaceuticals 483 Inspection

    Regeneron Pharmaceuticals 483 Inspection

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    55New York Medical College, Hawthorne  The Bristal at White Plains Regeneron, Tarrytown

    New York Medical College, Hawthorne The Bristal at White Plains Regeneron, Tarrytown

    Add to Reading List

    Source URL: westchesterny.org

    Language: English - Date: 2014-03-03 10:47:48
    56Rilonacept Regeneron, INN-rilonacept

    Rilonacept Regeneron, INN-rilonacept

    Add to Reading List

    Source URL: www.regeneron.com

    Language: English - Date: 2012-02-08 13:32:03
    57HIGHLIGHTS OF PRESCRIBING INFORMATION  DOSAGE FORMS AND STRENGTHS These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA.

    HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE FORMS AND STRENGTHS These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA.

    Add to Reading List

    Source URL: www.regeneron.com

    Language: English - Date: 2014-02-14 16:41:40
    58ZALTRAP® (ziv-aflibercept)

    ZALTRAP® (ziv-aflibercept)

    Add to Reading List

    Source URL: www.regeneron.com

    Language: English - Date: 2013-11-08 09:50:49
    59PRESS RELEASE  Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR - Both doses of investigational drug sarilumab met all three co-primary endpoints - New

    PRESS RELEASE Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR - Both doses of investigational drug sarilumab met all three co-primary endpoints - New

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-06-12 01:00:21
    60A Breakthrough Year 2012 Annual Report

    A Breakthrough Year 2012 Annual Report

    Add to Reading List

    Source URL: files.shareholder.com

    Language: English